EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 12 (Décembre 2009) Med Sci (Paris), 25 12 (2009) 1173-1176 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 12, Décembre 2009
Anticorps monoclonaux en thérapeutique
Page(s) 1173 - 1176
Section III - Un futur en développement
DOI https://doi.org/10.1051/medsci/200925121173
Published online 15 December 2009
  1. Kreis TE. Microinjected antibodies against the cytoplasmic domain of vesicularstomatitis virus glycoprotein block its transport to the cell surface. EMBO J 1986; 5 : 931–41. [Google Scholar]
  2. Orlandi R, Güssow DH, Jones PT, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86 : 3833–7. [Google Scholar]
  3. Biocca S, Neuberger MS, Cattaneo A. Expression and targeting of intracellular antibodies in mammalian cells. EMBO J 1990; 9 : 101–8. [Google Scholar]
  4. Biocca S, Ruberti F, Tafani M, et al. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. Biotechnology (NY) 1995; 13 : 1110–5. [Google Scholar]
  5. Philibert P, Stoessel A, Wang W, et al. A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol 2007; 7 : 81. [Google Scholar]
  6. Visintin M, Settanni G, Maritan A, et al. The intracellular antibody capture technology (IACT) : towards a consensus sequence for intracellular antibodies. J Mol Biol 2002; 317 : 73–83. [Google Scholar]
  7. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005; 23 : 1126–36. [Google Scholar]
  8. Tanaka T, Rabbitts TH. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. J Mol Biol 2008; 376 : 749–57. [Google Scholar]
  9. Saerens D, Pellis M, Loris R, et al. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. J Mol Biol 2005; 352 : 597–607. [Google Scholar]
  10. Nizak C, Martin-Lluesma S, Moutel S, et al. Recombinant antibodies against subcellular fractions used to track endogenous Golgi protein dynamics in vivo. Traffic 2003; 4 : 739–53. [Google Scholar]
  11. Nizak C, Monier S, del Nery E, et al. Recombinant antibodies to the small GTPase Rab6 as conformation sensors. Science 2003; 300 : 984–7. [Google Scholar]
  12. Dimitrov A, Quesnoit M, Moutel S, et al. Detection of GTP-tubulin conformation in vivo reveals a role for GTP remnants in microtubule rescues. Science 2008; 322 : 1353–6. [Google Scholar]
  13. Rothbauer U, Zolghadr K, Tillib S, et al. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 2006; 3 : 887–9. [Google Scholar]
  14. Marasco WA, Haseltine WA, Chen S. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gpl20 single-chain antibody. Proc Natl Acad Sci USA 1993; 90 : 7889–93. [Google Scholar]
  15. Cochet O, Kenigsberg M, Delumeau I, et al. lntracelIular expression of an antibody fragment-neutralizing p21 Ras promotes tumor regression. Cancer Res 1998; 58 : 1170–6. [Google Scholar]
  16. Cardinale A, Biocca S. The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases. Trends Mol Med 2008; 14 : 373–80. [Google Scholar]
  17. Lobato MN, Rabbitts TH. Intracellular antibodies and challenges facing their use as therapeutic agents. Trends Mol Med 2003; 9 : 390–6. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.